Literature DB >> 5232122

Circulatory effects of vasoactive drugs in current use for treatment of shock. A reclassification based on experimental and clinical study of their selective arterial and venous effects.

M H Weil, E C Bradley.   

Abstract

Mesh:

Year:  1966        PMID: 5232122      PMCID: PMC1806523     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN: 0028-7091


× No keyword cloud information.
  6 in total

1.  CIRCULATORY EFFECTS OF ANGIOTENSIN, LEVARTERENOL AND METARAMINOL IN THE TREATMENT OF SHOCK.

Authors:  V N UDHOJI; M H WEIL
Journal:  N Engl J Med       Date:  1964-03-05       Impact factor: 91.245

Review 2.  PHARMACOLOGIC APPROACH TO THE TREATMENT OF SHOCK.

Authors:  D M AVIADO
Journal:  Ann Intern Med       Date:  1965-05       Impact factor: 25.391

3.  THE HEMODYNAMICS OF SEPTIC SHOCK IN MAN AND IN THE DOG.

Authors:  J H DUFF; G MALAVE; D I PERETZ; H M SCOTT; L D MACLEAN
Journal:  Surgery       Date:  1965-07       Impact factor: 3.982

4.  Studies on the circulatory changes in the dog produced by endotoxin from gram-negative microorganisms.

Authors:  L D MACLEAN; W W SPINK; M B VISSCHER; M H WEIL
Journal:  J Clin Invest       Date:  1956-11       Impact factor: 14.808

5.  Use of isoproterenol and phenoxybenzamine in treatment of endotoxin shock.

Authors:  J A Vick; H P Ciuchta; J H Manthei
Journal:  J Pharmacol Exp Ther       Date:  1965-12       Impact factor: 4.030

6.  Vasodilator action of a "pressor amine," mephentermine (Wyamine), in circulatory shock.

Authors:  V N Udhoji; M H Weil
Journal:  Am J Cardiol       Date:  1965-12       Impact factor: 2.778

  6 in total
  2 in total

1.  Mechanisms of change in thoracic duct lymph flow during hypotensive states.

Authors:  N C Nelson; J L Nelson; W E Weldon; A R Vela
Journal:  Ann Surg       Date:  1970-06       Impact factor: 12.969

2.  Haemodynamic effects of isoprenaline in acute myocardial infarction.

Authors:  J Beregovich; H Reicher-Reiss; A Grishman
Journal:  Br Heart J       Date:  1972-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.